Glew R H, Pavuk R A, Shuster A, Alfred H J
Int J Clin Pharmacol Ther Toxicol. 1982 Dec;20(12):559-63.
The pharmacokinetics of vancomycin were studied during six episodes of peritonitis in four patients with chronic renal failure managed with chronic intermittent peritoneal dialysis. Following intravenous administration of vancomycin peritoneal concentrations ranged from undetectable to 22.5 micrograms/ml, and were 0-96% (mean 27%) of simultaneous serum concentrations. In view of the unpredictable penetration of vancomycin from serum into peritoneal fluid, we recommend that therapy for peritonitis due to staphylococci in patients undergoing peritoneal dialysis should include intraperitoneal administration of vancomycin.
对4例接受慢性间歇性腹膜透析治疗的慢性肾衰竭患者发生的6次腹膜炎进行了万古霉素的药代动力学研究。静脉注射万古霉素后,腹膜浓度范围为检测不到至22.5微克/毫升,为同期血清浓度的0-96%(平均27%)。鉴于万古霉素从血清进入腹膜液的渗透情况不可预测,我们建议对接受腹膜透析的患者因葡萄球菌引起的腹膜炎进行治疗时应包括腹腔内给予万古霉素。